EDGAR·FLOW

ACCURAY INC — Form 8-K

Filed October 6, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 78/100
What the filing says
Accuray stockholders approved financing with TCW Asset Management (primary lender, largest shareholder) on October 6, 2026: $40M term loan debt converted to convertible preferred stock, $15M new equity investment, up to $5M delayed draw term loan, covenant relief through end-2027, and reverse stock split (1-for-15 to 1-for-40 ratio, board discretion). Also appointed healthcare veteran Randy Meier to board. These transactions provide liquidity runway and financial flexibility.
Why this rating

$55M financing (63% of $86.9M market cap) is material; refinancing existing debt reduces burn but signals financial stress. Reverse split typically negative signal despite operational benefits. Governance addition positive.

Price action (we called it neutral)
before filing · preread
$0.26 ▲ 0.00%
at our read · unknown
$0.26
+10 min · unknown
$0.27 ▲ 1.91%
+30 min · unknown
$0.26 ▲ 0.84%
+1 hr · unknown
$0.27 ▲ 2.83%
+4 hrs · unknown
$0.25 ▼ 4.40%

The stock had already moved +0.00% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ ARAY · stock on Yahoo Finance ↗

See more from October 6, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.